Mirvetuximab soravtansine-gynx: first antibody/antigen-drug conjugate (ADC) in advanced or recurrent ovarian cancer
Giorgio Bogani, Robert L Coleman, Ignace Vergote, Toon van Gorp, Isabelle Ray-Coquard, Ana Oaknin, Ursula Matulonis, David O’Malley, Francesco Raspagliesi, Giovanni Scambia, Bradley J Monk
International Journal of Gynecologic Cancer Dec 2023, ijgc-2023-004924; DOI: 10.1136/ijgc-2023-004924